Full Press Release Details
NEXGEL Appoints Scott Henry, CFA to Board of Directors
LANGHORNE, Pa. - January 17, 2023 -
NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content
hydrogel products for healthcare and consumer applications, announced today the appointment of Scott Henry, CFA as a new independent
director to the Company's Board of Directors (the "Board"), effective immediately. Mr. Henry will also serve as a member
of the Board's Audit Committee.
"Scott brings a wealth of financial and operational
experience to NEXGEL, making him an ideal addition to our Board and Audit Committee," said Adam Levy, Chief Executive Officer of
NEXGEL. "Additionally, his vast network within the investment community and his extensive knowledge of the small and microcap company
landscape will be invaluable towards supporting our growth initiatives going forward. We are grateful to have Scott as part of our team."
Scott R. Henry, CFA, is a Managing Director, Senior
Research Analyst at ROTH Capital Partners with 20 years of sell-side coverage in the pharmaceutical, biotechnology and medical device
sectors. He has previously held positions with firms including Oppenheimer, Thomas Weisel Partners, ABN AMRO and Leerink Swann & Co.
Mr. Henry has received numerous awards, including rankings in the Wall Street Journal "Best on the Street" stock picking
survey, Forbes/Zacks Investment Research "Best Analysts" for the drugs category and Forbes.com/StarMine rankings for earnings
estimate accuracy. His investment views have been cited in the Wall Street Journal and the New York Times, and he has made
frequent appearances on CNBC, CBS MarketWatch and Bloomberg. Mr. Henry attended the University of Rhode Island and received an M.B.A.
with distinction from Cornell University.
Mr. Henry commented, "After
spending extensive time with Adam and the rest of the senior leadership team, I was excited to join the NEXGEL team as a member of the
Board and Audit Committee. NEXGEL presents a unique situation with solid assets, talented people and significant growth potential. Leveraging
my experience and industry relationships, I believe that together, we can capitalize on these opportunities."
NEXGEL is a leading provider of ultra-gentle, high-water-content
hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam,
cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations
to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Forward-Looking Statement
This press release contains
"forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private
Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe,"
"anticipate," "confidence," "estimate," "expect," "intend," "plan,"
"project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs,
such as "will," "should," "would," "may," and "could," are generally forward-looking
in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors
which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results,
performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking
statements, whether as a result of new information, a future event, or otherwise, except as required by law. For additional risks and
uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form
10-K for the year ended December 31, 2021, including but not limited to the discussion under "Risk Factors" therein, which
the Company filed with the SEC and which may be viewed at http://www.sec.gov/.
KCSA Strategic Communications
Raquel Cona / Michaela Fawcett
KCSA Strategic Communications
212.896.1204 / 978.995.4683